Currently, there are 1.44B common shares owned by the public and among those 1.43B shares have been available to trade.
The company’s stock has a 5-day price change of -3.80% and -2.42% over the past three months. FCX shares are trading 15.32% year to date (YTD), with the 12-month market performance up to 36.11% higher. It has a 12-month low price of $32.67 and touched a high of $55.15 over the same period. FCX has an average intraday trading volume of 12.05 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 0.72%, 8.96%, and 7.48% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Freeport-McMoRan Inc (NYSE: FCX) shares accounts for 84.41% of the company’s 1.44B shares outstanding.
It has a market capitalization of $70.20B and a beta (3y monthly) value of 1.90. The stock’s trailing 12-month PE ratio is 36.86, while the earnings-per-share (ttm) stands at $1.33. The company has a PEG of 1.47 and a Quick Ratio of 1.34 with the debt-to-equity ratio at 0.54. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.43% over the week and 2.32% over the month.
Earnings per share for the fiscal year are expected to increase by 3.94%, and 38.18% over the next financial year. EPS should grow at an annualized rate of 25.06% over the next five years, compared to -6.56% over the past 5-year period.
Looking at the support for the FCX, a number of firms have released research notes about the stock. Scotiabank stated their Sector Perform rating for the stock in a research note on September 30, 2024, with the firm’s price target at $52. UBS coverage for the Freeport-McMoRan Inc (FCX) stock in a research note released on September 04, 2024 offered a Buy rating with a price target of $55. Morgan Stanley was of a view on June 21, 2024 that the stock is Overweight, while BofA Securities gave the stock Buy rating on April 09, 2024, issuing a price target of $59. UBS on their part issued Neutral rating on January 16, 2024.
